|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2004-7-20
|
|
pubmed:abstractText |
Fibroblast growth factor 23 (FGF-23) is a recently identified polypeptide that promotes renal phosphate excretion and decreases serum 1,25-dihydroxyvitamin D3 (1,25D) levels. Serum FGF-23 levels are extraordinarily elevated in patients with end-stage renal failure.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
1523-6838
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
44
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
250-6
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:15264182-Adolescent,
pubmed-meshheading:15264182-Adult,
pubmed-meshheading:15264182-Aged,
pubmed-meshheading:15264182-Calcitriol,
pubmed-meshheading:15264182-Calcium,
pubmed-meshheading:15264182-Creatinine,
pubmed-meshheading:15264182-Enzyme-Linked Immunosorbent Assay,
pubmed-meshheading:15264182-Female,
pubmed-meshheading:15264182-Fibroblast Growth Factors,
pubmed-meshheading:15264182-Glomerulonephritis,
pubmed-meshheading:15264182-Humans,
pubmed-meshheading:15264182-Hyperparathyroidism, Secondary,
pubmed-meshheading:15264182-Kidney Failure, Chronic,
pubmed-meshheading:15264182-Kidney Tubules,
pubmed-meshheading:15264182-Male,
pubmed-meshheading:15264182-Middle Aged,
pubmed-meshheading:15264182-Nephrons,
pubmed-meshheading:15264182-Parathyroid Hormone,
pubmed-meshheading:15264182-Phosphates
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
Possible involvement of circulating fibroblast growth factor 23 in the development of secondary hyperparathyroidism associated with renal insufficiency.
|
|
pubmed:affiliation |
Division of Nephrology, Tokyo-Jikeikai Medical School, Aoto Hospital, Tokyo, Japan.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
